[go: up one dir, main page]

Carr Jr et al., 1989 - Google Patents

Effect of glycosaminoglycans on thrombin-and atroxin-induced fibrin assembly and structure

Carr Jr et al., 1989

Document ID
2045930502298747647
Author
Carr Jr M
Powers P
Publication year
Publication venue
Thrombosis and haemostasis

External Links

Snippet

This study was performed to quantitate the impact of several glycosaminoglycans (GAG) on fibrin assembly and structure. Gel formation was monitored as the increase in optical density at 633 nm subsequent to thrombin (2 NIH u/ml) or atroxin (0.10 mg/ml) addition to solutions …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Similar Documents

Publication Publication Date Title
Carr Fibrin formed in plasma is composed of fibers more massive than those formed from purified fibrinogen
Shen et al. Role of fibrinopeptide B release: comparison of fibrins produced by thrombin and Ancrod
Mosesson et al. Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin)
Bale et al. Effects of thrombospondin on fibrin polymerization and structure.
Collet et al. Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure
LeBoeuf et al. Effects of hyaluronic acid and other glycosaminoglycans on fibrin polymer formation
Carr Jr et al. At high heparin concentrations, protamine concentrations which reverse heparin anticoagulant effects are insufficient to reverse heparin anti-platelet effects
Edgar et al. The proteolytic action of ancrod on human fibrinogen and its polypeptide chains
Carr Jr et al. Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma
Carr Jr et al. Effects of poloxamer 188 on the assembly, structure and dissolution of fibrin clots
Carr et al. The effect of dextran 70 on the structure of plasma-derived fibrin gels
Nellenbach et al. Differential sialic acid content in adult and neonatal fibrinogen mediates differences in clot polymerization dynamics
Galanakis Anticoagulant albumin fragments that bind to fibrinogen/fibrin: possible implications
Beck et al. Functional evaluation of an inherited abnormal fibrinogen: Fibrinogen “Baltimore”
Carr Effect of hydroxyethyl starch on the structure of thrombin-and reptilase-induced fibrin gels
Carr Jr et al. Effect of glycosaminoglycans on thrombin-and atroxin-induced fibrin assembly and structure
Carr Jr et al. Heparin ablates force development during platelet mediated clot retraction
Shah et al. Physiological studies on fibrin network structure
Carr et al. Platelet factor 4 enhances fibrin fiber polymerization
Silberman et al. Effects of ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity
Lütjens et al. Polymerisation and crosslinking of fibrin monomers in diabetes mellitus
Siebenlist et al. The polymerization of fibrin prepared from fibrinogen Haifa (γ275Arg→ His)
Elgue et al. The effect of plasma antithrombin concentration on thrombin generation and fibrin gel structure
Karges et al. Therapeutic factor XIII preparations and perspectives for recombinant factor XIII
Carr et al. Granulocyte lysosomal cationic protein alters fibrin assembly: a possible mechanism for granulocyte control of clot structure